ClinicalTrials.govpublic full text
A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers
pulmonary disease, chronic obstructive, healthy subjects, pharmacokinetics, vilanterol, tolerability, safety, hepatic impairment, gw642444, gsk573719, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811881
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.